Drug profile · INN
baclofen
APO-BACLOFEN
baclofen (APO-BACLOFEN) is a gaba-b receptor agonist. Associated with Alphapharm Pty Ltd. Route of administration: intrathecal. Current US regulatory status: approved.
Drug details — baclofen
- US status
- approved
- Class
- —
- Route
- INTRATHECAL
- Patents
- 17
- Programs
- 12
- Data quality
- 0.89
Quick answer
baclofen (APO-BACLOFEN) is a gaba-b receptor agonist. Associated with Alphapharm Pty Ltd. Route of administration: intrathecal. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-B receptor agonist
Primary target: GABA-B receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Congress & event coverage
- PresentationScopeX
Pipeline programs
Related & competitor drugs
Related patents
-
US 12383522
Baclofen formulations and methods of minimizing patient exposure to metabolite variations
granted -
US 12350245
Stable oral suspensions of baclofen
granted -
US 12295929
Intravenous baclofen formulations and treatment methods
granted -
US 12011502
Compositions and methods of administering baclofen
granted -
US 11931328
Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
granted -
US 11857524
Stable oral suspensions of baclofen
granted -
US 11850225
Baclofen formulations and methods of minimizing patient exposure to metabolite variations
granted -
US 11654124
Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
granted -
US 11523984
Compositions and methods of administering baclofen
granted -
US 11491125
Baclofen formulations and methods of minimizing patient exposure to metabolite variations
granted -
US 10933042
Intravenous baclofen formulations and treatment methods
granted -
US 10350183
Intravenous baclofen formulations and treatment methods
granted -
US 9289408
High concentration baclofen preparations
granted -
US 8529916
High concentration baclofen preparations
granted -
US 8357379
High concentration baclofen preparations
granted -
US 8062647
High concentration baclofen preparations
granted -
US 7824697
High concentration baclofen preparations
granted
Frequently asked questions
What is baclofen?
baclofen (APO-BACLOFEN) is a gaba-b receptor agonist. Associated with Alphapharm Pty Ltd. Route of administration: intrathecal. Current US regulatory status: approved.
What is the brand name for baclofen?
APO-BACLOFEN is a marketed brand name for baclofen. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of baclofen?
baclofen has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.